Languages
English
Korean
English
About
Overview
History
Management Team
Board of Directors
Advisory Boards
Technology
Overview
TG-C
Publications
Product Pipeline
Overview
Applications
Clinical Trials
IR
Stock Data
PR
IR Material
Disclosure
Analyst Report
Partnering/Alliances
Contact
PR
IR
IR
Stock Data
PR
IR Material
Disclosure
Analyst Report
All News
2024
2023
2021
2020
2018
2017
2016
2015
2014
2012
2011
코오롱티슈진, 러시아서 TG-C 척추 적응증 특허 취득
Apr 9, 2024
코오롱티슈진, TG-C 척추 적응증 FDA 임상시험 승인
Dec 19, 2023
코오롱티슈진, TG-C 골관절염 치료기술 중국 특허 취득
Nov 3, 2023
코오롱티슈진, 글로벌 골관절염 학회(IWOAI)에서 TG-C 우수성 강조
Jul 5, 2023
코오롱티슈진 TG-C, 무릎에서 척추까지 적응증 확대 나선다
Apr 24, 2023
코오롱티슈진, 세계적인 골관절염학회에서 TG-C의 안전성과 유효성에 힘 실었다.
Apr 3, 2023
Kolon TissueGene To Expand Indications For TG-C
Dec 3, 2021
Kolon Tissuegene Announces Plans To Resume US Phase III Clinical Trial For TG-C
Apr 13, 2020
Kolon TissueGene Doses First Patient in US Phase III Clinical Trial
Nov 21, 2018
Kolon TissueGene to Expand License Agreement for INVOSSA™ with Kolon Life Science
Jun 26, 2018
1
2
3